Slingshot members are tracking this corporate initiative:
Amgen (AMGN) Agrees to Strategic Collaboration with Immatics Biotechnologies GmbH to Develop T-Cell Immunotherapies for a Range of Cancers
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date: Jan 09, 2017 Projected Implementation: Q1, 2017 Relevance Tracked Until: Q1, 2018
Don’t see a project related to the strategic initiative you care about?
Related Keywords T-cell Immunotherapies